Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Halidou Tinto, Louis Fries et al.|The Lancet Infectious Diseases|2022

Cited by 285